Breast Lesion Localization Methods Market By Type (Wire Localization, Radioisotope Localization, Radioactive Seed Localization, Radio Occult Lesion Localization, Magnetic Tracers, Others), By Biopsy Techniques (Fine Needle Aspiration Biopsy, Core Needle Biopsy, Surgical Biopsy, Incisional Biopsy, Excisional Biopsy, Vacuum-Assisted Breast Biopsy, Others), By End-user (Diagnostic Centres, Hospitals, Oncology Clinics, Ambulatory Surgical Centres), By Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2025
Global Breast Lesion Localization Methods Market is expected to reach USD 1,367.61 million by 2025 from USD 544.56 million in 2017, at a CAGR of 12.3% in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Major Players: Global Breast Lesion Localization Methods Market
Some of the major players operating in this market are:-
- CP Medical Inc.,
- Cianna Medical,
- STERYLAB S.r.l.,
- SOMATEX Medical Technologies GmbH,
- Elucent Medical,
- Tsunami S.r.l.,
- D.L. srl and
- Biomedical Srl among others.
INCREASING AWARENESS AMONG PEOPLE for the DIAGNOSIS OF BREAST CANCER
Various breast cancer control programmes are organized by government and non- government organizations to spread the awareness among people to improve the cancer literacy. In such awareness campaign, multiple sponsors and the health system are united to execute the awareness programme. The month of October is considered as the Breast Cancer Awareness month, which helps to increase and support for the awareness of breast cancer, early detection and treatment as well as palliative care of this disease. The pink ribbon is an international symbol of breast cancer awareness.
The UK’s breast cancer research charity, Breast Cancer Now, is the fundraisers, campaigners and researchers arranged the Breast Cancer Now Catalyst Programme in which they invite the leading researchers and pharmaceutical companies to pool resources.
RISING PREVALENCE OF BREAST CANCERAND INCREASING BREAST CANCER SURGERIES
- According to Cancer Research Organization UK, in 2014, 54,833 female cases are registered in UK.
- According to National Cancer Institute, of all cancer cases 15.0% represent the female breast cancer amongst common types of cancers.
- According to National Cancer Institute, in 2014 approximately 3,327,552 women living with female breast cancer in the U.S.
- According to Breast Cancer India, 232,714 women in U.S., 187,213 in China and 144,937 in India were detected with breast cancer
- According to World Cancer Research Fund International (WCRF), in 2012, approximately 1.7 million cases of breast cancer are diagnosed, which is the second most common cancer in women worldwide.
Market Segmentation: Global Breast Lesion Localization Methods Market
The global breast lesion localization methods market is segmented on the basis of type, biopsy techniques and end user. The report provides data for 2016 to 2025, 2017 being the current year while 2018 to 2025 is the forecast period for the report.
The global breast lesion localization market is segmented based on type into wire localization, radioisotope localization, magnetic tracers and others. Global breast lesion localization market is dominated by wire localization with 37.3% market share in 2017, growing at a CAGR of 12.0% in the forecast period. The radioisotope localization is further sub segmented into radioactive seed localization and radio occult lesion localization.
The global breast lesion localization market is segmented on the basis of biopsy techniques into fine needle aspiration biopsy, core needle biopsy, surgical biopsy, vacuum-assisted breast biopsy and others. Global breast lesion localization market is dominated by fine needle aspiration biopsy with 32.3% market share in 2017, growing at a CAGR of 12.5% in the forecast period. The surgical biopsy is further sub segmented into incisional biopsy and excisional biopsy.
The global breast lesion localization market is segmented on the basis of end user into diagnostic centres, hospitals, oncology clinics and ambulatory surgical centres. Global breast lesion localization market is dominated by hospitals with 35.8% market share in 2017, growing at a CAGR of 12.8% in the forecast period.
Based on geography, the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and Middle East and Africa..
Key Points: Global Breast Lesion Localization Methods Market
ARGON MEDICAL is going to dominate the global breast lesion localization methods market following with Cook Group and C. R. Bard, Inc. Some of the other players are CP Medical, Inc., Cianna Medical, STERYLAB S.r.l., SOMATEX Medical Technologies GmbH, Elucent Medical, Tsunami S.r.l., M.D.L. srl and Biomedical Srl among others.
The wire localization segment is dominating the global breast lesion localization methods market. However, magnetic tracers are expected to dominate the global breast lesion localization methods market during the forecast period.
The fine needle aspiration biopsy is dominating the breast lesion localization methods market with 32.3% market share, growing at a CAGR 12.5% in the forecast period 2017 to 2024.
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge Market Research